The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized by Magnus Group invites researchers, clinicians, healthcare professionals, scientists, academicians, and industry experts from across the globe to submit their original research and participate in this prestigious international event.
Scheduled for October 08–10, 2026, in Tokyo, Japan, with hybrid participation options, ICTO 2026 provides an exceptional platform to discuss groundbreaking discoveries, emerging technologies, and innovative therapeutic approaches in clinical and translational oncology.
Why Attend ICTO 2026?
- Present your latest research to an international audience.
- Engage with globally recognized oncology experts.
- Build collaborations with researchers and healthcare professionals.
- Gain valuable scientific feedback.
- Explore recent advancements in cancer diagnosis, treatment, immunotherapy, precision medicine, biomarkers, and translational research.
- Network with academic institutions, hospitals, research organizations, and industry leaders.
Who Should Attend?
- Oncologists
- Cancer Researchers
- Clinical Scientists
- Medical Professionals
- Surgeons
- Pathologists
- Pharmaceutical Researchers
- Healthcare Providers
- Faculty Members
- Students
- Industry Representatives
Submit Your Abstract
Researchers are encouraged to submit original research, case studies, and review presentations.
Abstract Submission
https://magnusconferences.com/cancer-oncology/submit-abstract
Conference Details
📅 October 08–10, 2026
📍 Tokyo, Japan | Hybrid Event
Website:
https://magnusconferences.com/cancer-oncology/
Join ICTO 2026 and contribute to advancing global cancer research while connecting with distinguished experts from around the world.
No comments:
Post a Comment